CHA2DS2‐VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule‐out

Background Chest‐pain patients deemed safe for discharge from internal medicine wards might still be at risk for adverse outcomes. Hypothesis CHA2DS2‐VASc score improves risk stratification of low‐risk chest‐pain patients discharged after acute coronary syndrome (ACS) rule‐out. Methods We accessed m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cardiology (Mahwah, N.J.) N.J.), 2018-04, Vol.41 (4), p.539-543
Hauptverfasser: Topaz, Guy, Haisraely, Ory, Shacham, Yacov, Beery, Gil, Shilo, Lotan, Kassem, Nuha, Pereg, David, Kitay‐Cohen, Yona
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 543
container_issue 4
container_start_page 539
container_title Clinical cardiology (Mahwah, N.J.)
container_volume 41
creator Topaz, Guy
Haisraely, Ory
Shacham, Yacov
Beery, Gil
Shilo, Lotan
Kassem, Nuha
Pereg, David
Kitay‐Cohen, Yona
description Background Chest‐pain patients deemed safe for discharge from internal medicine wards might still be at risk for adverse outcomes. Hypothesis CHA2DS2‐VASc score improves risk stratification of low‐risk chest‐pain patients discharged after acute coronary syndrome (ACS) rule‐out. Methods We accessed medical records of patients who were admitted to internal medicine wards at a single medical center during 2010–2016 and discharged following an ACS rule‐out. Patients were classified according to CHA2DS2‐VASc score: 0–1 (low), 2–3 (intermediate), >3 (high). Primary endpoint was occurrence of ACS at 1 year; 30‐day and 1‐year all‐cause mortality (ACM) were secondary outcomes. Results Of 12 449 patients, 7057 (57%) had low, 3781 (30%) intermediate, and 1611 (13%) high CHA2DS2‐VASc scores. Compared with a low score, intermediate and high scores were associated with significantly increased risk for 1‐year ACS during the first year (OR: 2.89, 95% CI: 1.91–4.37, P 
doi_str_mv 10.1002/clc.22925
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6489928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2032539837</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2285-256fb7e3f3b8b68b5cc315a4cbbe3491fa828ac3833fc892c18608385d840dbb3</originalsourceid><addsrcrecordid>eNpVUU1v1DAQtRCILoUD_8AS57SOvUnGF6RVoLTSShxKe7XsibPrymsvdsJqb_0J3Pl3_BLcD1XiNKOZN2_ezCPkY83Oasb4OXo841zy5hVZ1FLwCjrRvSYLVreskhzkCXmX812BMuDiLTnhsoWubdoF-dNfrviXa_73_vft6hppxpgs1WGg6F1wqD2N84RxZzONI93rydkwZXpw05bi1uap1Fygg8u41WljBzqmuKMuTDaFMr2zg0MXLD3oNGQ6Ru_jwYUN1ThPlpZ1Meh0pPkYhjJoaZq9LWrK1vfkzah9th-e4ym5ufj6o7-s1t-_XfWrdbXnHJqKN-1oOitGYcC0YBpEUTd6icZYsZT1qIGDRgFCjAiSYw0tAwHNAEs2GCNOyecn3v1silwsBybt1T65XVGmonbq_05wW7WJv1S7BFneWwg-PROk-HMuP1F3cX64PivOBG-EBNEV1PkT6uC8Pb7Q10w9mKiKierRRNWv-8dE_ANyXpWV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2032539837</pqid></control><display><type>article</type><title>CHA2DS2‐VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule‐out</title><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Topaz, Guy ; Haisraely, Ory ; Shacham, Yacov ; Beery, Gil ; Shilo, Lotan ; Kassem, Nuha ; Pereg, David ; Kitay‐Cohen, Yona</creator><creatorcontrib>Topaz, Guy ; Haisraely, Ory ; Shacham, Yacov ; Beery, Gil ; Shilo, Lotan ; Kassem, Nuha ; Pereg, David ; Kitay‐Cohen, Yona</creatorcontrib><description>Background Chest‐pain patients deemed safe for discharge from internal medicine wards might still be at risk for adverse outcomes. Hypothesis CHA2DS2‐VASc score improves risk stratification of low‐risk chest‐pain patients discharged after acute coronary syndrome (ACS) rule‐out. Methods We accessed medical records of patients who were admitted to internal medicine wards at a single medical center during 2010–2016 and discharged following an ACS rule‐out. Patients were classified according to CHA2DS2‐VASc score: 0–1 (low), 2–3 (intermediate), &gt;3 (high). Primary endpoint was occurrence of ACS at 1 year; 30‐day and 1‐year all‐cause mortality (ACM) were secondary outcomes. Results Of 12 449 patients, 7057 (57%) had low, 3781 (30%) intermediate, and 1611 (13%) high CHA2DS2‐VASc scores. Compared with a low score, intermediate and high scores were associated with significantly increased risk for 1‐year ACS during the first year (OR: 2.89, 95% CI: 1.91–4.37, P &lt; 0.01 and OR: 4.84, 95% CI: 3.02–7.74, P &lt; 0.01, respectively). Each 1‐point increase in CHA2DS2‐VASc was associated with a 37% increased risk for 1‐year ACS. A higher CHA2DS2‐VASc score was associated with significantly higher 30‐day ACM. Hazard ratios for 30‐day ACM were 1.9 (95% CI: 1.1–3.4, P = 0.03) and 4.4 (95% CI: 2.4–7.9, P &lt; 0.01) for intermediate and high CHA2DS2‐VASc scores, respectively, compared with a low score. Each 1‐point increase in CHA2DS2‐VASc score was associated with 43% increased risk for 30‐day mortality. Conclusions High CHA2DS2‐VASc score (&gt;3) was associated with adverse outcomes among chest‐pain patients discharged from internal medicine wards following ACS rule‐out.</description><identifier>ISSN: 0160-9289</identifier><identifier>EISSN: 1932-8737</identifier><identifier>DOI: 10.1002/clc.22925</identifier><identifier>PMID: 29687656</identifier><language>eng</language><publisher>New York: Wiley Periodicals, Inc</publisher><subject>Acute Coronary Syndrome (ACS) ; Acute coronary syndromes ; CHA2DS2‐VASc Score ; Chest Pain ; Clinical Investigations ; Clinical outcomes ; Internal medicine ; Medicine ; Pain</subject><ispartof>Clinical cardiology (Mahwah, N.J.), 2018-04, Vol.41 (4), p.539-543</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-7989-5817 ; 0000-0003-0805-3185 ; 0000-0002-5627-9712</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489928/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489928/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,27901,27902,45550,45551,53766,53768</link.rule.ids></links><search><creatorcontrib>Topaz, Guy</creatorcontrib><creatorcontrib>Haisraely, Ory</creatorcontrib><creatorcontrib>Shacham, Yacov</creatorcontrib><creatorcontrib>Beery, Gil</creatorcontrib><creatorcontrib>Shilo, Lotan</creatorcontrib><creatorcontrib>Kassem, Nuha</creatorcontrib><creatorcontrib>Pereg, David</creatorcontrib><creatorcontrib>Kitay‐Cohen, Yona</creatorcontrib><title>CHA2DS2‐VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule‐out</title><title>Clinical cardiology (Mahwah, N.J.)</title><description>Background Chest‐pain patients deemed safe for discharge from internal medicine wards might still be at risk for adverse outcomes. Hypothesis CHA2DS2‐VASc score improves risk stratification of low‐risk chest‐pain patients discharged after acute coronary syndrome (ACS) rule‐out. Methods We accessed medical records of patients who were admitted to internal medicine wards at a single medical center during 2010–2016 and discharged following an ACS rule‐out. Patients were classified according to CHA2DS2‐VASc score: 0–1 (low), 2–3 (intermediate), &gt;3 (high). Primary endpoint was occurrence of ACS at 1 year; 30‐day and 1‐year all‐cause mortality (ACM) were secondary outcomes. Results Of 12 449 patients, 7057 (57%) had low, 3781 (30%) intermediate, and 1611 (13%) high CHA2DS2‐VASc scores. Compared with a low score, intermediate and high scores were associated with significantly increased risk for 1‐year ACS during the first year (OR: 2.89, 95% CI: 1.91–4.37, P &lt; 0.01 and OR: 4.84, 95% CI: 3.02–7.74, P &lt; 0.01, respectively). Each 1‐point increase in CHA2DS2‐VASc was associated with a 37% increased risk for 1‐year ACS. A higher CHA2DS2‐VASc score was associated with significantly higher 30‐day ACM. Hazard ratios for 30‐day ACM were 1.9 (95% CI: 1.1–3.4, P = 0.03) and 4.4 (95% CI: 2.4–7.9, P &lt; 0.01) for intermediate and high CHA2DS2‐VASc scores, respectively, compared with a low score. Each 1‐point increase in CHA2DS2‐VASc score was associated with 43% increased risk for 30‐day mortality. Conclusions High CHA2DS2‐VASc score (&gt;3) was associated with adverse outcomes among chest‐pain patients discharged from internal medicine wards following ACS rule‐out.</description><subject>Acute Coronary Syndrome (ACS)</subject><subject>Acute coronary syndromes</subject><subject>CHA2DS2‐VASc Score</subject><subject>Chest Pain</subject><subject>Clinical Investigations</subject><subject>Clinical outcomes</subject><subject>Internal medicine</subject><subject>Medicine</subject><subject>Pain</subject><issn>0160-9289</issn><issn>1932-8737</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVUU1v1DAQtRCILoUD_8AS57SOvUnGF6RVoLTSShxKe7XsibPrymsvdsJqb_0J3Pl3_BLcD1XiNKOZN2_ezCPkY83Oasb4OXo841zy5hVZ1FLwCjrRvSYLVreskhzkCXmX812BMuDiLTnhsoWubdoF-dNfrviXa_73_vft6hppxpgs1WGg6F1wqD2N84RxZzONI93rydkwZXpw05bi1uap1Fygg8u41WljBzqmuKMuTDaFMr2zg0MXLD3oNGQ6Ru_jwYUN1ThPlpZ1Meh0pPkYhjJoaZq9LWrK1vfkzah9th-e4ym5ufj6o7-s1t-_XfWrdbXnHJqKN-1oOitGYcC0YBpEUTd6icZYsZT1qIGDRgFCjAiSYw0tAwHNAEs2GCNOyecn3v1silwsBybt1T65XVGmonbq_05wW7WJv1S7BFneWwg-PROk-HMuP1F3cX64PivOBG-EBNEV1PkT6uC8Pb7Q10w9mKiKierRRNWv-8dE_ANyXpWV</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Topaz, Guy</creator><creator>Haisraely, Ory</creator><creator>Shacham, Yacov</creator><creator>Beery, Gil</creator><creator>Shilo, Lotan</creator><creator>Kassem, Nuha</creator><creator>Pereg, David</creator><creator>Kitay‐Cohen, Yona</creator><general>Wiley Periodicals, Inc</general><general>John Wiley &amp; Sons, Inc</general><scope>K9.</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7989-5817</orcidid><orcidid>https://orcid.org/0000-0003-0805-3185</orcidid><orcidid>https://orcid.org/0000-0002-5627-9712</orcidid></search><sort><creationdate>201804</creationdate><title>CHA2DS2‐VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule‐out</title><author>Topaz, Guy ; Haisraely, Ory ; Shacham, Yacov ; Beery, Gil ; Shilo, Lotan ; Kassem, Nuha ; Pereg, David ; Kitay‐Cohen, Yona</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2285-256fb7e3f3b8b68b5cc315a4cbbe3491fa828ac3833fc892c18608385d840dbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acute Coronary Syndrome (ACS)</topic><topic>Acute coronary syndromes</topic><topic>CHA2DS2‐VASc Score</topic><topic>Chest Pain</topic><topic>Clinical Investigations</topic><topic>Clinical outcomes</topic><topic>Internal medicine</topic><topic>Medicine</topic><topic>Pain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Topaz, Guy</creatorcontrib><creatorcontrib>Haisraely, Ory</creatorcontrib><creatorcontrib>Shacham, Yacov</creatorcontrib><creatorcontrib>Beery, Gil</creatorcontrib><creatorcontrib>Shilo, Lotan</creatorcontrib><creatorcontrib>Kassem, Nuha</creatorcontrib><creatorcontrib>Pereg, David</creatorcontrib><creatorcontrib>Kitay‐Cohen, Yona</creatorcontrib><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cardiology (Mahwah, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Topaz, Guy</au><au>Haisraely, Ory</au><au>Shacham, Yacov</au><au>Beery, Gil</au><au>Shilo, Lotan</au><au>Kassem, Nuha</au><au>Pereg, David</au><au>Kitay‐Cohen, Yona</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CHA2DS2‐VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule‐out</atitle><jtitle>Clinical cardiology (Mahwah, N.J.)</jtitle><date>2018-04</date><risdate>2018</risdate><volume>41</volume><issue>4</issue><spage>539</spage><epage>543</epage><pages>539-543</pages><issn>0160-9289</issn><eissn>1932-8737</eissn><abstract>Background Chest‐pain patients deemed safe for discharge from internal medicine wards might still be at risk for adverse outcomes. Hypothesis CHA2DS2‐VASc score improves risk stratification of low‐risk chest‐pain patients discharged after acute coronary syndrome (ACS) rule‐out. Methods We accessed medical records of patients who were admitted to internal medicine wards at a single medical center during 2010–2016 and discharged following an ACS rule‐out. Patients were classified according to CHA2DS2‐VASc score: 0–1 (low), 2–3 (intermediate), &gt;3 (high). Primary endpoint was occurrence of ACS at 1 year; 30‐day and 1‐year all‐cause mortality (ACM) were secondary outcomes. Results Of 12 449 patients, 7057 (57%) had low, 3781 (30%) intermediate, and 1611 (13%) high CHA2DS2‐VASc scores. Compared with a low score, intermediate and high scores were associated with significantly increased risk for 1‐year ACS during the first year (OR: 2.89, 95% CI: 1.91–4.37, P &lt; 0.01 and OR: 4.84, 95% CI: 3.02–7.74, P &lt; 0.01, respectively). Each 1‐point increase in CHA2DS2‐VASc was associated with a 37% increased risk for 1‐year ACS. A higher CHA2DS2‐VASc score was associated with significantly higher 30‐day ACM. Hazard ratios for 30‐day ACM were 1.9 (95% CI: 1.1–3.4, P = 0.03) and 4.4 (95% CI: 2.4–7.9, P &lt; 0.01) for intermediate and high CHA2DS2‐VASc scores, respectively, compared with a low score. Each 1‐point increase in CHA2DS2‐VASc score was associated with 43% increased risk for 30‐day mortality. Conclusions High CHA2DS2‐VASc score (&gt;3) was associated with adverse outcomes among chest‐pain patients discharged from internal medicine wards following ACS rule‐out.</abstract><cop>New York</cop><pub>Wiley Periodicals, Inc</pub><pmid>29687656</pmid><doi>10.1002/clc.22925</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-7989-5817</orcidid><orcidid>https://orcid.org/0000-0003-0805-3185</orcidid><orcidid>https://orcid.org/0000-0002-5627-9712</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-9289
ispartof Clinical cardiology (Mahwah, N.J.), 2018-04, Vol.41 (4), p.539-543
issn 0160-9289
1932-8737
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6489928
source Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Acute Coronary Syndrome (ACS)
Acute coronary syndromes
CHA2DS2‐VASc Score
Chest Pain
Clinical Investigations
Clinical outcomes
Internal medicine
Medicine
Pain
title CHA2DS2‐VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule‐out
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A55%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CHA2DS2%E2%80%90VASc%20score%20and%20clinical%20outcomes%20of%20patients%20with%20chest%20pain%20discharged%20from%20internal%20medicine%20wards%20following%20acute%20coronary%20syndrome%20rule%E2%80%90out&rft.jtitle=Clinical%20cardiology%20(Mahwah,%20N.J.)&rft.au=Topaz,%20Guy&rft.date=2018-04&rft.volume=41&rft.issue=4&rft.spage=539&rft.epage=543&rft.pages=539-543&rft.issn=0160-9289&rft.eissn=1932-8737&rft_id=info:doi/10.1002/clc.22925&rft_dat=%3Cproquest_pubme%3E2032539837%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2032539837&rft_id=info:pmid/29687656&rfr_iscdi=true